I agree Kalaka, these results are amazing. No doubt about it. Furthermore these results are backed up by the outstanding results achieved in the other 6 indications that MESO is perusing.
IMO a massive deal is coming because the loose consortium to keep this new technology down is starting to fall apart.
The old model is falling apart Pharma stocks are down ,patents are expiring, insurance companies are questioning $$ to benefits. Patients want cures not maintenance. Just a matter of time that a medium size pharma makes a great deal with MESO,ATHX ,CUR, or any of the others.
What I like is no public company in the stem cell sector has yet to sell out cheap. Other than ACTC for 380 mill which was a steal.
Were on the cusp....
Fantastic, page-3
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |